{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:26:36Z","timestamp":1771032396719,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejogrb.2016.11.012","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T19:03:38Z","timestamp":1479236618000},"page":"36-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Association of R156R single nucleotide polymorphism of the ERCC2 gene with the susceptibility to ovarian cancer"],"prefix":"10.1016","volume":"208","author":[{"given":"Hanna","family":"Romanowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena M.","family":"Michalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Samulak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Malinowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Szaflik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Bie\u0144kiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Smolarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2016.11.012_bib0005","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0010","series-title":"Cancer in Poland in 2006","first-page":"30","article-title":"Corpus uteri cancer","author":"Wojciechowska","year":"2008"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0015","doi-asserted-by":"crossref","first-page":"h4443","DOI":"10.1136\/bmj.h4443","article-title":"Diagnosis of ovarian cancer","volume":"351","author":"Sundar","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0020","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2008.04.030","article-title":"XPD helicase structures and activities: insights into the cancer and aging phenotypes from XPD mutations","volume":"133","author":"Fan","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0025","first-page":"1513","article-title":"Polymorphisms in DNA repair genes and associations with cancer risk","volume":"11","author":"Goode","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2169\/internalmedicine.54.3256","article-title":"XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis","volume":"54","author":"Guo","year":"2015","journal-title":"Intern Med"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0035","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1007\/s13277-015-3066-2","article-title":"Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer","volume":"36","author":"Geredeli","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0040","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1097\/MD.0000000000000330","article-title":"Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis","volume":"93","author":"Peng","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0045","doi-asserted-by":"crossref","first-page":"9699","DOI":"10.7314\/APJCP.2014.15.22.9699","article-title":"The XPD Lys751Gln polymorphism has predictive value in colorectal cancer patients receiving oxaliplatin-based chemotherapy: a systemic review and meta-analysis","volume":"15","author":"Qian","year":"2014","journal-title":"Asian Pac J Cancer Prev."},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0050","doi-asserted-by":"crossref","first-page":"16765","DOI":"10.3748\/wjg.v20.i44.16765","article-title":"Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies","volume":"20","author":"Yang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0055","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s13277-014-2825-9","article-title":"DNA repair gene polymorphisms in B cell non-Hodgkin's lymphoma","volume":"36","author":"Bahceci","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0060","doi-asserted-by":"crossref","first-page":"109593","DOI":"10.1155\/2015\/109593","article-title":"An association between single nucleotide polymorphisms of Lys751Gln ERCC2 gene and ovarian cancer in polish women","volume":"2015","author":"Michalska","year":"2015","journal-title":"Adv Med"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0065","doi-asserted-by":"crossref","first-page":"11243","DOI":"10.1007\/s13277-014-2379-x","article-title":"Association between the XPD\/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies","volume":"35","author":"Wu","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0070","doi-asserted-by":"crossref","first-page":"941","DOI":"10.7314\/APJCP.2013.14.2.941","article-title":"DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy","volume":"14","author":"Kang","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0075","first-page":"455","article-title":"The ERCC2 K751 polymorphism is associated with breast cancer risk","volume":"35","author":"Hosseini","year":"2009","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0080","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/SLA.0b013e318216f374","article-title":"Genetic variants in DNA repair predicts the survival of patients with esophageal cancer","volume":"253","author":"Lee","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0085","first-page":"355","article-title":"Associations between ERCC2 polymorphisms and gliomas","volume":"10","author":"Caggana","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0090","article-title":"The R156R ERCC2 polymorphism as a risk factor of endometrial cancer","author":"Michalska","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0095","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1215\/S1152851705000037","article-title":"ERCC1 and ERCC2 polymorphisms and adult glioma","volume":"7","author":"Wrensch","year":"2005","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0100","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.4238\/2015.March.31.17","article-title":"Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk","volume":"14","author":"Zhou","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0105","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1007\/s13277-014-1969-y","article-title":"Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk","volume":"35","author":"Hui","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1017\/thg.2014.4","article-title":"Association between ERCC2 Lys751Gln polymorphism and lung cancer risk: a meta-analysis involving 23,370 subjects","volume":"17","author":"Tan","year":"2014","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0115","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1038\/srep04112","article-title":"Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population","volume":"4","author":"Ni","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0120","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1007\/s13277-013-1461-0","article-title":"Single nucleotide polymorphisms (SNPs) of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women","volume":"35","author":"Smolarz","year":"2014","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.canep.2009.08.002","article-title":"Polymorphisms in the nucleotide excision repair gene ERCC2\/XPD and risk of non-Hodgkin lymphoma","volume":"33","author":"Worrillow","year":"2009","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejogrb.2016.11.012_bib0130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/FPC.0b013e3280115e63","article-title":"Single nucleotide polymorphisms of the DNA repair gene XPD\/ERCC2 alter mRNA expression","volume":"17","author":"Wolfe","year":"2007","journal-title":"Pharmacogenet Genomics"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211516310235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211516310235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:38:09Z","timestamp":1759556289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211516310235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":26,"alternative-id":["S0301211516310235"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.11.012","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of R156R single nucleotide polymorphism of the ERCC2 gene with the susceptibility to ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}